Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Life Sciences
|
January 29, 2013
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Bauke Buwalda, Sanne B Schagen
Current Neurology and Neuroscience Reports
|
March 29, 2012
Chemotherapy-related cognitive dysfunction
Jeffrey S Wefel, Sanne B Schagen
Psycho-Oncology
|
July 20, 2011
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients
Sanne B Schagen, Enny Das, Ivar Vermeulen
Brain Imaging and Behavior
|
August 13, 2013
Functional MRI studies in non-CNS cancers
Michiel B de Ruiter, Sanne B Schagen
Acta Oncologica (Stockholm, Sweden)
|
June 23, 2016
Neurocognitive function of lymphoma patients after treatment with chemotherapy
Hans Wouters, Joke W Baars, Sanne B Schagen
The Clinical Neuropsychologist
|
February 12, 2025
A tool for false positive rate estimation in cognitive impairment research: Handling correlated tests, small samples, and composite criteria
Joost A Agelink van Rentergem, Sanne B Schagen
Journal of the International Neuropsychological Society : JINS
|
March 11, 2014
Systemically treated breast cancer patients and controls: an evaluation of the presence of noncredible performance
Jeffrey S Wefel, Rozemarijn L Kornet, Sanne B Schagen
Neuro-Oncology Advances
|
June 24, 2026
Cancer treatment-related cognitive impairment
Bryan J Neth, Sanne B Schagen, Jeffrey S Wefel
Nature Reviews. Clinical Oncology
|
July 22, 2015
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
Wilbert Zwart, Huub Terra, Sabine C Linn, et al.
The Lancet. Oncology
|
March 1, 2011
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S Wefel, Janette Vardy, Tim Ahles, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Life Sciences
|
January 29, 2013
Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Bauke Buwalda, Sanne B Schagen
Current Neurology and Neuroscience Reports
|
March 29, 2012
Chemotherapy-related cognitive dysfunction
Jeffrey S Wefel, Sanne B Schagen
Psycho-Oncology
|
July 20, 2011
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients
Sanne B Schagen, Enny Das, Ivar Vermeulen
Brain Imaging and Behavior
|
August 13, 2013
Functional MRI studies in non-CNS cancers
Michiel B de Ruiter, Sanne B Schagen
Acta Oncologica (Stockholm, Sweden)
|
June 23, 2016
Neurocognitive function of lymphoma patients after treatment with chemotherapy
Hans Wouters, Joke W Baars, Sanne B Schagen
The Clinical Neuropsychologist
|
February 12, 2025
A tool for false positive rate estimation in cognitive impairment research: Handling correlated tests, small samples, and composite criteria
Joost A Agelink van Rentergem, Sanne B Schagen
Journal of the International Neuropsychological Society : JINS
|
March 11, 2014
Systemically treated breast cancer patients and controls: an evaluation of the presence of noncredible performance
Jeffrey S Wefel, Rozemarijn L Kornet, Sanne B Schagen
Neuro-Oncology Advances
|
June 24, 2026
Cancer treatment-related cognitive impairment
Bryan J Neth, Sanne B Schagen, Jeffrey S Wefel
Nature Reviews. Clinical Oncology
|
July 22, 2015
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
Wilbert Zwart, Huub Terra, Sabine C Linn, et al.
The Lancet. Oncology
|
March 1, 2011
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer
Jeffrey S Wefel, Janette Vardy, Tim Ahles, et al.
Page
of 12